Implementation of the National Strategy for Pandemic Influen

Moderators: Jim DeVito, Justine Cooper

Stephen Eisel
Posts: 3281
Joined: Fri Jan 26, 2007 9:36 pm

Implementation of the National Strategy for Pandemic Influen

Postby Stephen Eisel » Wed Jul 18, 2007 10:38 am

Implementation of the National Strategy for Pandemic Influenza ... 717-5.html

(here is part of the article)

Today, The White House Homeland Security Council Issued A One-Year Report On The Administration's Progress In Implementing The National Strategy For Pandemic Influenza. The United States is better positioned today to detect an outbreak of pandemic flu earlier, to support an international effort to contain the pandemic in its earliest stages, to limit the spread of a pandemic, and to save lives.

In May 2006, The Administration Issued The National Strategy For Pandemic Influenza Implementation Plan, Which Provides A Roadmap To Achieve The Federal Government's Pandemic Preparedness And Response Goals.
We Have Made Great Strides Over The Past Year To Complete The Actions Outlined In The Implementation Plan. Eighty-six percent of all actions due within 12 months under the Implementation Plan have been completed. The remaining 14 percent of actions are in progress and are expected to be completed by the 18-month mark.[1]
We Are Confronting The Threat Of An Influenza Pandemic At Its Source

The United States Has Made Pivotal Contributions To Control The International Spread Of H5N1. Through the International Partnership on Avian and Pandemic Influenza, we are working with affected countries and international partners to detect, contain, and prevent animal outbreaks; reduce human exposure to the virus; and enhance planning and preparedness for future outbreaks.

The United States Is Working On Avian Influenza Issues In More Than 100 Countries To Combat The Spread Of Avian Influenza And Prepare For A Possible Pandemic.
Over the past year, the U.S. Government has supported the training of more than 129,000 animal health workers and 17,000 human health workers in H5N1 surveillance and outbreak response.
We have deployed more than 300,000 personal protective equipment kits to more than 70 countries for use by surveillance workers and outbreak-response teams.
U.S. experts have provided vital technical expertise to national investigations of actual outbreaks of H5N1 in countries on three continents and provided technical assistance, commodities, and logistical or financial support to 39 of the 60 countries and jurisdictions affected by H5N1.
The United States is supporting efforts to improve laboratory diagnosis and early warning networks in 75 countries.
The United States Is Working To Expand On-The-Ground Surveillance Capacity And Improve Knowledge About The Movement And Changes In H5N1 On A Global Scale By:
Creating the Wild Bird Global Avian Influenza Network for Surveillance project;
Enhancing the Global Emerging Infections Surveillance and Response System;
Funding the World Health Organization Global Outbreak Alert and Response Network;
Expanding the network of Global Disease Detection Centers; and
Providing the genome sequences of more than 2,250 human and avian influenza isolates as a result of the Influenza Genome Sequencing Project to track genetic changes in viral strains.
The United States Is Now Better Prepared To Respond To An Outbreak Of Pandemic Influenza

The United States Has Developed Protocols And Trained Personnel To Support An International Effort To Contain The Pandemic In Its Earliest Stages. We have pre-positioned stockpiles of personal protective equipment, decontamination kits, and antiviral medications overseas to complement global efforts to contain pandemic outbreaks.

The Administration Has Made Significant Investments In Vaccines, Antiviral Medications, And Research That Will Help Safeguard Our Nation And Benefit The World. The Administration is investing in the expansion of vaccine manufacturing capacity, the advanced development of new cell-based vaccines, vaccine-stretching technologies known as adjuvants, and the establishment and maintenance of pre-pandemic vaccine stockpiles.

We have invested more than $1 billion in the development of new vaccine technologies.

Return to “Lakewood Health & Wellness”

Who is online

Users browsing this forum: No registered users and 5 guests